Skip to main content
Premium Trial:

Request an Annual Quote

Harvard Med School Purchases Array Sample-Prep System from Beckman Coulter

NEW YORK, Feb. 11 (GenomeWeb News) - The Harvard Medical School-Partners HealthCare Center for Genetics and Genomics has purchased an automated microarray sample-preparation system from Beckman Coulter as part of a collaborative development effort, Beckman announced yesterday.

 

Under terms of the agreement, the two organizations will work closely together to "evaluate and refine" application methods on an automated platform based on Beckman's Biomek FX laboratory automation workstation, the company said.

 

The modified system will be used to prepare target RNA for genotyping on Affymetrix chips.

 

"The addition of this system will allow our expression profiling facility to accommodate larger scope microarray analysis projects for gene expression and mapping arrays," said Vance Morgan, director of laboratory operations for HPCGG.

 

Financial terms of the agreement were not disclosed.

The Scan

Octopus Brain Complexity Linked to MicroRNA Expansions

Investigators saw microRNA gene expansions coinciding with complex brains when they analyzed certain cephalopod transcriptomes, as they report in Science Advances.

Study Tracks Outcomes in Children Born to Zika Virus-Infected Mothers

By following pregnancy outcomes for women with RT-PCR-confirmed Zika virus infections, researchers saw in Lancet Regional Health congenital abnormalities in roughly one-third of live-born children.

Team Presents Benchmark Study of RNA Classification Tools

With more than 135 transcriptomic datasets, researchers tested two dozen coding and non-coding RNA classification tools, establishing a set of potentially misclassified transcripts, as they report in Nucleic Acids Research.

Breast Cancer Risk Related to Pathogenic BRCA1 Mutation May Be Modified by Repeats

Several variable number tandem repeats appear to impact breast cancer risk and age at diagnosis in almost 350 individuals carrying a risky Ashkenazi Jewish BRCA1 founder mutation.